Finance
Results: 34021-34032 of 37124

FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data at the Society for Neuro-Oncology 2023 Annual Meeting

Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability







